Log in
NASDAQ:CTSO

Cytosorbents Earnings Date, Estimates & History

$8.36
+0.17 (+2.08 %)
(As of 11/27/2020 05:00 PM ET)
Add
Compare
Today's Range
$8.27
Now: $8.36
$8.47
50-Day Range
$7.65
MA: $8.40
$8.98
52-Week Range
$3.49
Now: $8.36
$11.74
Volume9,532 shs
Average Volume576,589 shs
Market Capitalization$360.95 million
P/E RatioN/A
Dividend YieldN/A
Beta0.4

Earnings

Cytosorbents (NASDAQ:CTSO) Earnings Information

Cytosorbents last issued its earnings results on November 4th, 2020. The medical research company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.07. Cytosorbents has generated ($0.60) earnings per share over the last year. Cytosorbents has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 4th, 2021 based off prior year's report dates.

Cytosorbents Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cytosorbents (NASDAQ:CTSO) Earnings Estimates

2020 EPS Consensus Estimate: ($0.23)
2021 EPS Consensus Estimate: ($0.08)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.11)($0.02)($0.07)
Q2 20203($0.09)($0.02)($0.06)
Q3 20204($0.14)($0.02)($0.08)
Q4 20205($0.06)$0.01($0.03)
Q1 20211($0.03)($0.03)($0.03)
Q2 20211($0.04)($0.04)($0.04)
Q3 20211($0.02)($0.02)($0.02)
Q4 20211$0.01$0.01$0.01
Q1 20221$0.02$0.02$0.02
Q2 20221$0.00$0.00$0.00

Cytosorbents (NASDAQ CTSO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/4/2021
(Estimated)
       
11/4/20209/30/2020($0.09)($0.02)($0.02)Transcript
8/4/20206/30/2020($0.08)($0.08)($0.08)$9.79 million$9.80 millionTranscript
5/5/20203/31/2020($0.14)($0.10)($0.10)$7.14 million$8.71 millionTranscript
3/5/202012/31/2019($0.16)($0.12)($0.13)$7.35 million$7.43 millionTranscript
11/5/2019Q3 2019($0.13)($0.21)($0.21)$6.49 million$6.10 millionTranscript
8/6/2019Q2 2019($0.14)($0.11)($0.11)$6.53 million$6.23 millionN/A
5/7/20193/31/2019($0.18)($0.15)($0.15)$6.03 million$5.19 millionN/A
3/7/201912/31/2018($0.13)($0.17)($0.17)$6.08 million$6.08 millionTranscript
11/7/20189/30/2018($0.14)($0.10)($0.10)$5.79 million$5.74 millionTranscript
8/2/2018Q2 2018($0.12)($0.1920)($0.19)$5.08 million$5.76 millionN/A
5/8/2018Q1($0.13)($0.1020)($0.10)$4.56 million$4.93 millionN/A
3/8/2018Q4 2017($0.10)($0.12)($0.12)$4.56 million$4.65 millionN/A
11/9/2017Q3 2017($0.07)($0.07)($0.07)$3.67 million$3.45 millionN/A
8/7/2017Q2 2017($0.06)($0.04)($0.04)$3.29 million$3.57 millionListen
5/8/2017Q1 2017($0.11)($0.05)($0.05)$2.99 million$3.11 millionListen
3/3/2017Q4 2016($0.10)($0.16)($0.16)$2.59 million$3.08 millionN/A
11/7/2016Q3($0.11)($0.11)($0.11)$2.35 million$2.14 millionListen
8/9/2016Q216($0.09)($0.12)($0.12)$2.18 million$1.90 millionN/A
5/9/2016Q116($0.10)($0.08)($0.08)$1.73 million$1.80 millionN/A
3/9/2016Q415($0.08)($0.08)($0.08)$1.51 million$1.76 millionN/A
11/13/2015Q315($0.10)($0.11)($0.11)$1.26 million$1.30 millionListen
8/13/2015Q215($0.11)$0.05$0.05$0.92 million$0.96 millionListen
5/11/2015Q115($0.13)($0.11)($0.03)$0.80 million$0.72 millionListen
11/12/2014Q3 2014($0.25)($0.25)($0.25)$1.28 million$1.16 millionN/A
8/12/2014Q2 2014($0.01)($0.01)($0.25)$1.13 million$1.03 millionN/A
5/14/2014Q1 2014($0.25)($0.25)($0.25)$1.02 million$1.06 millionN/A
3/31/2014Q4 2013($0.01)($0.01)($0.25)$8.34 million$0.88 millionN/A
11/6/2013Q3 2013($0.25)($0.25)($0.25)$0.70 million$0.88 millionN/A
8/14/2013Q2 2013($0.25)($0.25)($0.25)$0.29 millionN/A
5/16/2013Q1 2013($0.25)($0.25)$0.85 million$0.37 millionN/A
4/3/2013Q4 2012($0.25)($0.25)N/A
11/21/2012Q3 2012($0.25)($0.25)($0.25)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.